Nuchido Ltd

Life Sciences
Aim of funding: 
HMRC Advance Assurance received: 

Nuchido Ltd


Nuchido Ltd was established to address the growing consumer demand for cosmeceutical products. Cosmeceuticals are the combination of cosmetics and pharmaceuticals, and are cosmetic products with bioactive ingredients that are validated by the science community.  According to The Company’s market research, both ‘savvy’ consumers and major ‘brand’ companies are actively seeking scientifically proven products, where the underlying clinical data can stand up to scrutiny in supporting any product benefit claims.

The Company has built a complement of experienced scientists and physicians who have the necessary skills, experience and medical background to bring the Company’s proposition to market. The team will be leveraging their clinical research backgrounds to add value and credibility to the Nuchido brand.

The Company intends to use their own molecular level expertise in conjunction with the latest ‘cutting edge’ medical discoveries that are attempting to identify the processes that contribute to skin ageing. Specifically, the Company is seeking to develop a range of products to be branded under the title Di Forelli, utilising a range of in-house originated bioactive molecules.


In 2013, the global anti-aging market was estimated to be worth US$122.3bn. The anti-aging market is estimated to see a compound annual growth rate of 7.8% between 2013 and 2019 [1]. 

The United States is a key market in the global cosmetic industry, generating estimated revenue of approximately US$62bn in 2016. Many women today use creams in their attempts to slow the ageing process. In 2014, facial anti-ageing skincare products were ranked second among skincare categories, with sales amounting to US$1.15bn [2].  



Information on this webpage relates to and is provided by Deepbridge Advisers Limited.

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Deepbridge Capital LLP, Deepbridge Advisers Limited and Enterprise Partners LLP (together "the Sponsors," or "Sponsor) do not provide specific individual advice on the suitability of investments with regard to a potential investor's individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.